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Viruses  cause  a variety  of  illnesses  in  humans,  yet  only  a  few  antiviral  drugs  have  been  developed;  thus,
new  antiviral  drugs  are  urgently  needed.  Plants  could  be  a good  source  of  antiviral  drugs,  they  do  not  have
mobility  and  can  only  defend  themselves  by  producing  compounds  against  pathogens  such  as  viruses
in  their  own  ﬁx  environment.  These  compounds  may  have  the  potential  to inhibit  animal  and  human
viruses  as well.
In  this  study,  a fast  and  reliable  method  for screening  plant  extracts  for  speciﬁc  antiviral  activity  against
Herpes  simplex  virus  type-1  (HSV-1)  was  developed.  This  method  distinguishes  between  host  cell  deathlant antiviral activity
yotpathic effect
uciferase
oxicity
iral infectivity
due to infectivity  and  multiplicity  of the  virus  versus  toxicity  of  the  plant  extract.  Extracts  from  80 plant
and  plant  organs  were  screened  using  this  approach.  Six  plant  extracts  showed  potential  to exert  speciﬁc
HSV-1  growth  inhibition  activity.  In  two  cases,  different  organs  from  the  same  plant  showed  similar
active  results.  With  this  method  it is  possible  to  screen  a  large  number  of extracts  in a  rapid  and  accurate
way  to  detect  antiviral  substances  against  HSV-I  and other  viruses.
© 2014  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND. Introduction
Herpes simplex virus type-1 (HSV-1) is one of the most common
uman pathogens, infecting 40–80% of people worldwide (Kelly
t al., 2009). It most commonly causes mucocutaneous infections,
esulting in recurrent orolabial lesions (Kelly et al., 2009), and in
dults HSV infection can cause ocular herpes and/or encephalitis.
owever, HSV-1 also has the capability of infecting and establishing
atency in neurons, and in neonates it can cause encephalitis and
evere disseminated infection with neurological impairment and
igh mortality (Kelly et al., 2009).
HSV-I virions consist of an inner nucleoprotein core comprising
 linear dsDNA genome of 152 kbp that is enclosed in an icosa-
edral capsid shell. The nucleocapsid is surrounded by a layer of
roteinaceous material designated the tegument, which is enclosed
n an envelope of host cell-derived lipids containing virus-encoded
lycoproteins (Kelly et al., 2009).
After primary infection, the virus establishes lifelong latency
n sensory neurons of the peripheral nervous system. Sporadic
∗ Corresponding author at: Hadassah Academic College, Jerusalem 91120, Israel.
el.: +972 2 6291975; fax: +972 2 6292675.
E-mail address: President@hadassah.ac.il (B. Fridlender).
ttp://dx.doi.org/10.1016/j.jviromet.2014.08.007
166-0934/© 2014 The Authors. Published by Elsevier B.V. This is an open access article unlicense (http://creativecommons.org/licenses/by-nc-nd/3.0/).
reactivation of latent virus triggered by exogenous factors can lead
to virus replication followed by recrudescent infection (Gescher
et al., 2011).
There is an ever-increasing need for novel and improved antivi-
ral agents as alternatives to the popular drug acyclovir (ACV) and
other nucleoside derivatives used worldwide against HSV-1 and
many other viruses. This need is dictated by several drawbacks
associated to the commonly used antiherpetic drugs, including
development of anti-ACV resistant mutant viruses as well as side
effects such as nausea, vomiting, and headache, and the fact that
ACV is not highly effective in recurrent virus attacks (Yarmolinsky
et al., 2010).
Plants are known to be self-sustaining chemical chameleons
capable of synthesizing different compounds according to their
needs. It is well known that plants defend themselves based on
the challenges encountered (Raskin and Rippol, 2004). Many plants
synthesize antimicrobial compounds as a mechanism of protec-
tion against a number of pathogenic agents. Plants do not have
mobility and can only defend themselves by producing compounds
against all the different enemies they encounter. Some plants are
tolerant to various plant viruses, and might produce antiviral com-
pounds that confer this resistance (Lindbo et al., 1993). These
compounds may  have the potential to inhibit animal and human
viruses (Yarmolinsky et al., 2010).
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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To date, many natural plant compounds have demonstrated
ntiviral effects in clinical studies, in animal experiments, and
n vitro (Knipping et al., 2012). Ficus benjamina is known as a
lant with anti-HSV-1 effect that effectively inhibits infection of
ero cells by HSV-1 (Yarmolinsky et al., 2010). Similarly, Men-
ha longifolia, Origanum syriacum, and Melissa ofﬁcinalis have been
igorously promoted as having antiviral agents that are effective
gainst several viruses (Allahverdiyev et al., 2004; Geuenich et al.,
008; Vimalanathan and Hudson, 2012). However, a fast and reli-
ble method for detecting potential new antiviral products in plants
s required.
Viruses multiply within cells; thus, a direct method that exa-
ines the presence of a virus in cells is required to be able to track
iral cultures accurately. Since plant extracts with potential anti-
SV-1 effect may  also be toxic to animal cells, it is important to use
n approach that distinguishes between antiviral and animal cell
oxicity characteristics, since death of cells carrying target viruses
ould be related to cell toxicity of the extract as well as, or in lieu
f, any antiviral effect.
In this study a two-step method was developed for screening
lant extracts for their speciﬁc antiviral activity against HSV-1. The
rst step detects the toxicity of the extract to the infected cells while
he second step identiﬁes inhibition of viral replication. After con-
rming the validity of the technology on several plant extracts, the
ntiviral activity was screened in extracts derived from 80 different
lants.
. Materials and methods
.1. Cell lines
Monkey kidney Vero cells were cultured in Dulbecco’s Modiﬁed
agle’s Medium (DMEM, Sigma–Aldrich, St Louis, MO,  USA) supple-
ented with 10% fetal calf serum (FCS, Sigma–Aldrich), penicillin
100 U/ml), and streptomycin sulfate (100 g/ml) at 37 ◦C in 5% CO2.
ero cells were kindly provided by Dr. A. Panet (Department of
irology, The Hebrew University – Hadassah School of Medicine,
erusalem, Israel).
.2. Viruses
HSV-1 was chosen for this assay because of the importance of
nding novel agents to inhibit this speciﬁc virus, and because of
ts ability to grow easily in cell cultures. In addition, acyclovir, a
nown antiviral agent could be used as a positive control. HSV
7+/pR20.5/5 was the chosen viral strain selected for this assay
ecause it contains the -galactosidase (-gal) gene, which is under
he control of the Rous sarcoma virus (RSV) promoter, and the green
uorescent protein (GFP) gene, which is under the control of the
ytomegalovirus (CMV) promoter (Kolodkin-Gal et al., 2008). Both
enes are expressed constitutively and, for purpose of the research,
ere inserted at the Us5 gene locus. It was previously shown that
nactivation of Us5 does not otherwise affect virus growth in vitro
r the virulence or kinetics of latency in vivo (Thomas et al., 1999).
Virus infectivity was  detected indirectly by analyzing cell viabil-
ty and directly by identifying the virus through its -galactosidase
ctivity using the ≡eta-Glo Assay system (Promega, Madison, WI,
SA).
The virus was kindly provided by Dr. A. Panet (Department of
irology, The Hebrew University – Hadassah School of Medicine,
erusalem, Israel). To propagate the virus, Vero cells were infected
nd the virus was harvested from the cell pellet, puriﬁed on a 10%
ucrose cushion (Sigma–Aldrich), and titrated by plaque assay on
ero cells (Kolodkin-Gal et al., 2008).ical Methods 208 (2014) 138–143 139
2.3. Cell infection
Cells were seeded in 96-well plates (1 × 104 cells per well) in
DMEM,  for 24 h and then infected with 0.25 M.O.I. (multiplicity of
infection), of HSV–(RSV-gal) in 50 l DMEM,  with no FCS. At 2 h
post-infection, 10% FCS and DMEM were added to achieve a total
volume of 100 l, and cells were incubated for a further 46 h at
37 ◦C in 5% CO2.
2.4. Plant samples
Three types of plants were selected to facilitate a sensitivity
analysis of testing for lack of activity as an indication of virus
viability: (1) a plant with no known antiviral activity (Cucumis
sativus peel); (2) a plant known to be generally toxic (Nerium ole-
ander) (Turan et al., 2006)); and (3) plants that have been reported
as antiviral agents (F. benjamina,  Mentha longiﬁolia,  O. syriacum,
M. ofﬁcinalis (Allahverdiyev et al., 2004; Geuenich et al., 2008;
Vimalanathan and Hudson, 2012; Yarmolinsky et al., 2010).
2.5. Preparation of plant ethanolic extracts
Ethanolic extracts were prepared from different plants and
organs (leaves of F. benjamina,  M. longifolia, O. syriacum, M. ofﬁ-
cinalis; peels of C. sativus; and others). Two  grams of plant tissues
with 5 ml  of 60% ethanol were crushed using a mortar and pestle
and clariﬁed by centrifugation (1800 rpm for 10 min) twice. 1 ml
of the supernatant was  evaporated in an open 5 cm nonabsorbent
plate in a biological hood for 45 min. The volume of the evaporated
supernatant was  measured and DMEM with no serum was added to
a total volume of 1 ml.  The ﬁnal extract concentration was  adjusted
to be 400 g/ml.
2.6. Preparation of plant extracts for Immunocytology assays
Plant powders (20 g) were dissolved in 1 ml  boiling water and
boiled for an additional 5 min. The extracts were vortexed for 3 min
and clariﬁed by centrifugation (3000 rpm for 10 min). The super-
natant was collected and re-centrifuged under the same conditions.
The supernatant was  collected again and used for Immunocytology
assays.
2.7. MTS cell viability assay
The MTS  assay is based upon the ability of mitochondrial dehy-
drogenase to convert MTS  substrate (3-(4,5-dimethylthiazol-
2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium, inner salt (Sigma–Aldrich) to insoluble formazan,
which has a purple color (Buttke et al., 1993). Vero cells were
seeded in 96-well plates (1 × 104 cells per well) and infected
with 0.25 M.O.I. of HSV–(RSV-gal) in 100 l DMEM with various
concentrations of plant extracts. After 48 h, 20 l MTS  was added
to the Vero cells and the mixtures were incubated at 37 ◦C for
1 h. Absorbance was measured at 490 nm to assess cell metabolic
activity.
2.8. Beta-Glo assay for ˇ-gal detection
The beta-glo assay system (Promega) is a homogeneous bio-
luminescent assay that couples -galactosidase activity to a
luciferase reaction. -galactosidase catalyzes a reaction in which
the substrate (d-luciferin-o--galactopyranoside) is cleaved to
release luciferin. This luciferin serves as a substrate for luciferase
that is present in the reagent. As a result of the luciferase activity,
oxyluciferin is formed and light is emitted (Hannah et al., 2003).
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Fig. 1. Effects of Mentha longifolia extract on virus infectivity and cell viability. (A) Vero cells were infected with HSV-1 at a multiplicity of infection (MOI) of 0.25 in the
absence or presence of increasing doses (0.04, 0.4, 4, 20, 40 mg/ml) of M. longifolia extracts or 10 M of acyclovir (Acv). Infected cells were analyzed for -galactosidase (-gal)
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onzyme-speciﬁc activity using the Beta-Glo assay as described in Section 2. (B) Mo
oses  of M. longifolia extracts or 10 M of acyclovir (Con Acv). Cell viability was ana
f  three independent experiments.
Vero cells were seeded in white 96-well plates (1 × 104 cells
er well), infected with 0.25 M.O.I. of HSV–(RSV-gal) in 100 l
MEM with various concentrations of plant extracts. After 48 h,
ero cells were incubated with 100 l Beta-Glo solution at room
emperature for 30 min. Luciferase activity was measured using a
hemiluminescence imaging system (MicroChemi, Berthold Tech-
ologies, Bad Wildbad, Germany).
Varying concentrations of plant extracts were added to Vero
ells during infection with HSV-1. The extracts were checked for
wo types of activity: toxicity of the extracts to the Vero cells, by
sing MTS, and infectivity of the virus, by MTS  and by detecting
-Glo. The advantage of this method is the possibility to simul-
aneously analyze both the toxicity and the functional antiviral
otential of the extracts.
.9. Immunocytology assay
The Immunocytology assay was used to detect the expression of
iral glycoproteins on the surface of infected cells using polyclonal
ntibodies.
Vero cells were seeded in 96-well plates (1 × 104 cells per well),
nfected with 0.25 M.O.I. of HSV–(RSV-gal) in 100 l DMEM with
arious concentrations of plant extracts. After 48 h, Vero cells
ere ﬁxed using 100 l 3.8% formaldehyde in PBS, for 10 min
t room temperature, washed three times with 1× PBS and
locked for 30 min  at room temperature with 100 l 1% BSA in
BS (blocking solution). Cells were washed with 1× PBS 0.02%
ween 20 and treated with 50 l polyclonal Rabbit anti-HSV-1
lycoproteins (Biotest) diluted 1:100 with blocking solution for
 h at room temperature. After three washes with 1× PBS 0.05%
ween 20, cells were treated for 30 min  with 50 l goat anti-rabbit
gG HRP conjugated (Biotest), and washed again. 100 l of TMB
ig. 2. Effect of toxic plant (Bellis silvestiria) extracts on virus infectivity and cell viability. (
f  increasing doses (0.4, 4, 12, 20 mg/ml) of Bellis silvestiria extract, or 10 M of acyclovir
eta-Glo assay. (B) Mock-infected and Vero cells infected with HSV-1 at an MOI of 0.25 in
r  10 M of acyclovir. Cell viability was analyzed by MTS  assay. Data reﬂect means ± SD (ected and Vero cells infected with HSV-1 at 0.25 MOI  in the presence of increasing
 by MTS  assay. Data reﬂect means ± SD (n = 3 replicates). Results are representative
(3,3′,5,5′-tetramethylbenzidine; MW = 240.4) (Biotest) substrate
was added and the absorbance of the soluble blue product was
measured at 650 nm.
In all assays, 10 M of acycloguanosine (Sigma–Aldrich), a
known antiviral agent, was used as a positive control. Extracts
were added during the adsorption stage of viral infection. Since
viruses can adsorb a variety of carbohydrates and glycoproteins
with no speciﬁcity, it was  necessary to determine whether the plant
extracts could inhibit viruses during their adsorption stage in a non-
speciﬁc way. A naïve extract (C. sativus extract) was  added before
and after the adsorption stage of infection.
3. Results
Results of experiments showing viral infectivity and Vero cell
viability after addition of varying concentrations of plant extracts
following infection with HSV-1 are shown in Figs. 1–4. As expected,
C. sativus,  the naïve plant with no expected toxicity, showed no
antiviral activity, and N. oleander was  toxic to the Vero cells (results
are not shown). Ethanol extracts of M. longiﬁolia at concentrations
of 4 mg/ml  or higher inhibited HSV-1 (Fig. 1A). At a concentration of
4 mg/ml  there was no cytopathic effect on either infected or non-
infected cells, which showed almost the same viability (Fig. 1B).
However, at higher concentrations (20–40 mg/ml) M. longiﬁolia had
a toxic effect and the viability of both infected and noninfected
cells was  reduced (Fig. 1B). Similarly, F. benjamina,  O. syriacum, and
M. ofﬁcinalis showed anti-HSV-1 activity at speciﬁc concentrations,
and at high concentrations all three had cell toxicity (results are not
shown).
A naïve extract (C. sativus extract) was added before and after
the adsorption stage of infection. There was no difference in the
result in either case (result not shown).
A) Vero cells were infected with HSV-1 at an MOI  of 0.25 in the absence or presence
 (Acv). Infected cells were analyzed for -gal enzyme-speciﬁc activity by using the
 the presence of increasing doses (0.4, 4, 12, 20 mg/ml) of Bellis silvestiria extracts,
n = 3 replicates). Results are representative of three independent experiments.
S. Matza-Porges et al. / Journal of Virological Methods 208 (2014) 138–143 141
Fig. 3. Effect of naïve (Bellevalia ﬂexuosa) plant extract on virus infectivity and cell viability. (A) Vero cells were infected with HSV-1 at 0.25 MOI  in the absence or presence
o  (Acv). Infected cells were analyzed for -gal enzyme-speciﬁc activity using the Beta-Glo
a nce of increasing doses of B. ﬂexuosa extract, (0.4, 4, 12, 20 mg/ml) or 10 M of acyclovir).
C Results are representative of three independent experiments.
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Table 1
Plant samples found to have ability to inhibit HSV-1 growth.
Name of plant (Genus specie)
Fumana thymifolia,  leaves
Fumana thymifolia,  ﬂowers
Geranium rotundifolium,  stems
Campanula hierosolymitana, above-ground organs
F
w
f
i
af  increasing doses (0.4, 4, 12, 20 mg/ml) of B. ﬂexuosa extract, or 10 M of acyclovir
ssay.  (B) Mock-infected and Vero cells infected with HSV-1 at 0.25 MOI in the prese
ell  viability was analyzed by MTS  assay. Data reﬂect means ± SD (n = 3 replicates). 
Following validation of the technique, a total of 80 plant
amples from organs of various plants were tested. The plants
ere classiﬁed into three different groups: toxic plants, non-
oxic/noninhibitory plants, and plants with potential growth
nhibitory activity for HSV-1 without Vero cell toxicity. Fig. 2 shows
llustrative results from testing with a crude extract from a toxic
lant (Bellis silverstris). When the extract was administered in con-
entrations higher than 4 mg/ml, HSV-1 could not replicate (Fig. 2A)
nd Vero cells did not survive (Fig. 2B).
Crude extract from Bellevalia ﬂexuosa is an example of an agent
hat was both nontoxic and noninhibitory, and it is referred to as
 naïve plant (Fig. 3). HSV-1 was able to replicate at all concen-
rations of the extract (Fig. 3A), and the viability of infected cells
as reduced due to virus growth (Fig. 3B). Fig. 4 shows an exam-
le of a plant that was not toxic to Vero cells (Fumana thymifolia)
nd has potential HSV-1 growth inhibitory activity. HSV-1 was not
ble to replicate in the presence of this extract (Fig. 4A), while there
as no cytopathic effect on either infected or noninfected cells at
oncentrations of 0.4–4 mg/ml  (Fig. 4B).
Among the 80 plants and plant organs screened, six extracts
rom several plants and plant organs showed some potential
nhibitory activity against HSV-1 at a range of 400 g/ml–12 mg/ml
f crude extract (Table 1).
In order to rule out false-positive results due to a speciﬁc effect of
he extracts on the reporter gene promoters, an Immunocytology
ssay was used as another direct anti-viral assay. This Immuno-
ytology assay tests viral viability by checking viral glycoprotein
xpression on the surface of the host cell.
ig. 4. Effect of a potential HSV-1 growth-inhibiting active plant extract (Fumana thymif
ith  HSV-1 at 0.25 MOI  in the absence or presence of increasing doses (0.4, 4, 12, 20 mg/m
or  -gal enzyme-speciﬁc activity using the Beta-Glo assay as described in Section 2. (B)
ncreasing doses (0.4, 4, 12, 20 mg/ml) of F. thymifolia extract or 10 M of acyclovir. Cell via
re  representative of three independent experiments.Sedum sediforme, stems
Sedum sediforme, leaves
Crude extract from 12 plants, some of them with known anti-
viral activity (Tareq et al., 2005; Liao et al., 2010; Zhou et al.,
2014), were screened against the HSV-1 virus. As can be seen in
Fig. 5, the Immunocytology assay corroborates the ﬁndings of the
-gal assay (Fig. 5A and C). Extract from the plant Flos Lonicerae
showed anti-HSV effect at 10 mg/ml  in both assays, while having
no cytopathological effect on the host cells. At concentration higher
than 15 mg/ml  the extract is toxic to the cells (Fig. 5B).
4. Discussion
Despite the large number of viral diseases, there are still very
few antiviral agents that effectively treat this pathogenesis. Plants
can be a very valuable source of new antiviral molecules, since they
combat viral infections constantly during their life cycle. The avail-
ability of a fast and reliable screening method for new potential
antiviral drugs will accelerate the selection of plants with antivi-
ral effects and stimulate the development of new plant-derived
olia)  that affects virus infectivity but not cell viability. (A) Vero cells were infected
l) of F. thymifolia extract, or 10 M of acyclovir (Acv). Infected cells were analyzed
 Mock-infected and Vero cells infected with HSV-1 at 0.25 MOI  in the presence of
bility was  analyzed by MTS  assay. Data reﬂect means ± SD (n = 3 replicates). Results
142 S. Matza-Porges et al. / Journal of Virological Methods 208 (2014) 138–143
Fig. 5. Effect of a potential HSV-1 growth-inhibiting active plant extract (Flos Lonicerae) that affects virus infectivity (veriﬁed by -glo assay and Immunocytology) but not
cell  viability. (A) Vero cells were infected with HSV-1 at 0.25 MOI  in the absence or presence of increasing doses (5, 10, 15, 18 mg/ml) of Flos Lonicerae extract, or 10 M of
acyclovir  (Acv). Infected cells were analyzed for -gal enzyme-speciﬁc activity using the Beta-Glo assay as described in Section 2. (B) Mock-infected and Vero cells infected
with  HSV-1 at 0.25 MOI in the presence of increasing doses (5, 10, 15, 18 mg/ml) of Flos Lonicerae extract or 10 M of acyclovir. Cell viability was  analyzed by MTS  assay.
(C)  Infected cells were analyzed by immunocytology as described in Section 2. Data reﬂect means ± SD (n = 3 replicates). Results are representative of three independent
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ntiviral agents. Since viruses grow within cells and are cytopathic,
 differentiation should be made between cell death due to tox-
city of the tested antiviral agent and death due to viral infection.
aluable antiviral activity must have the capability of inhibiting
he growth of a virus without exerting toxicity on the infected cells.
he method described in this study addresses this requirement and
acilitates identiﬁcation of plants with antiviral bioactivities that
an be further studied for their potential therapeutic effects.
In the present study we developed a new method for the detec-
ion of plant extracts capable of inhibiting HSV-1 infectivity. The
ethod described here clearly differentiates between cell death
ue to infectivity and multiplicity of the virus versus cell death due
o the toxicity of the plant extract. This fast, two-step method may
e used in wide screening for extracts with potential antiviral prop-
rties. Extracts that prevent viral multiplication without affecting
ell viability should be considered as potential antiviral agents that
ay  warrant further research.
Cell viability was assessed using MTS, which measures virus
nfectivity indirectly by detecting cell viability. Virus infectivity was
easured directly using the HSV–RSV-gal virus, which is an HSV-
 recombinant virus with the reporter gene for -galactosidase.
eta-Glo substrate products break down to luciferase enzyme sub-
trate and cause reactionary light that can be measured accurately
sing a luciferase reading appliance. Adding these products enables
irect detection of the presence of the virus. Analyzing the result
f cell viability by MTS  and the presence of the virus by beta-Glo
ssay enables accurate identiﬁcation of extracts with the potential
or virus inhibition without cell toxicity.
This detection system may  be used only if two conditions exist:
he virus must have a -galactosidase reporter gene in its genome,
nd the reporter gene must not affect its infectivity. HSV-1 car-
ies a reporter gene under the control of the Rous sarcoma virus
RSV) promoter, and it was previously shown that insertion of thisreporter gene in HSV-1 does not affect virus growth in vitro or the
virulence and latency kinetics of the virus in vivo (Thomas et al.,
1999). This method is applicable for studies of other cytopathic
viruses carrying a -galactosidase reporter gene that does not affect
viral infectivity.
It is possible to use other methods, such as real-time PCR (Van
Elden et al., 2001) or Immunocytology assay to directly measure
virus infectivity. However, the key for a successful screening tech-
nique is simultaneous measurement of cell viability and virus
multiplicity. PCR techniques do not require the -galactosidase
reporter gene, but the detection stage is more difﬁcult and less
suitable for quick screening of a large number of samples.
In the -gal assay, viral activity is detected by monitoring -
galactosidase gene expression. This gene is under the control of
the Rous sarcoma virus (RSV) promoter, and the green ﬂuores-
cent protein (GFP) gene, which in turn is under the control of the
cytomegalovirus (CMV) promoter. A speciﬁc effect of the extract on
these promoters can give false-positive results in the -gal assay,
although in such a case cell death is expected to be observed in
the MTS  assay. In order to conﬁrm the results of the -gal assay an
additional independent immnocytology assay was utilized. In this
assay, viral glycoproteins expressed on the surface of the host cell
membrane are detected using speciﬁc antibodies. If the decrease in
the protein’s level correlates with the reduction in -gal gene level
this will indicate that the extracts affect virus propagation and not
speciﬁcally inhibits the reporter gene promoter. Twelve extracts
of plants were screened using the Immunocytology assay in par-
allel with the -gal and MTS  assays. In all 12 extracts there was a
clear correlation between the -gal results and the Immunocytol-
ogy assay results. Extract from the plant Flos Lonicerae, with known
anti-viral activity, (Zhou et al., 2014) showed potential to exert
HSV-1 growth inhibition activity. The fact that all three approaches
support the result expected, the use of the simpler and faster
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of  Callissia fragrans and Simmondsia chinensis leaf extracts in vitro. Open Virol. J.S. Matza-Porges et al. / Journal of V
-gal assay for large scale screenings of potential anti-viral activity
n plant extracts can be adopted.
Ethanol plays an important role in extract formulation, but has
 toxic effect on cells; thus it is important to signiﬁcantly reduce
ts concentration in extracts used for treatment. This was  accom-
lished by evaporation and further resuspension of the dry material
n buffer. Lyophilizing the extract before adding it to the cells is also
ecommended.
Previous studies have reported differential antiviral plant
xtract activity on HSV-1 in comparison with other viruses. Extracts
f M.  longifolia, F. benjamina,  Oreganum syriacum, and M. ofﬁci-
alis were reported to exert antiviral activity against other viruses
Knipping et al., 2012; Orhan et al., 2011; Yarmolinsky et al., 2009).
hese plants were used as a reference for antiviral potential plants
gainst HSV-1.
Extracts from 80 plant and plant organs were screened using this
pproach. As shown in Table 1, six plants extracts showed potential
o exert HSV-1 growth inhibition activity. Other plants exerted cell
oxicity without antiviral potential, or were naïve, with no antivi-
al potential and no toxicity. In two cases, different organs from
he same plants showed similar active results. Both the leaves and
tems of Sedum sediforme, and the leaves and ﬂowers of F. thymifolia
howed anti-HSV-1 activity. Evidence of a viral inhibitory growth
ffect from more than one organ of a single plant provides added
vidence of the accuracy and validity of this method.
This method may  be also used after fractionation and isolation
f compounds from plant extract and will enable further analysis
nd investigation of newly anti-viral agents.
In conclusion, the new method described here enables the
etection of potential antiviral agents from a large number of
xtracts quickly and accurately.
The advantage of this method is the possibility to independently
nalyze both the toxicity and the functional anti-viral potential of
he extracts in a two-step process.
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